Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children

about

Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.US-Based Drug Cost Parameter Estimation for Economic Evaluations.A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.

P2860

Q35577840-046B406B-349C-4FBF-866A-45AFB3DE2CA8 Q35756371-7E576D05-6851-4C90-B2A8-9C9F78468DAE Q38541022-C47EA193-7B8D-4ABC-AC04-0BAAA021E1AA

P2860

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children

Item

http://www.wikidata.org/entity/Q37308287

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost-effectiveness of latent t ...... nephrotic syndrome in children

@en

Cost-effectiveness of latent t ...... ephrotic syndrome in children.

@nl

type

Item

label

Cost-effectiveness of latent t ...... nephrotic syndrome in children

@en

Cost-effectiveness of latent t ...... ephrotic syndrome in children.

@nl

prefLabel

Cost-effectiveness of latent t ...... nephrotic syndrome in children

@en

Cost-effectiveness of latent t ...... ephrotic syndrome in children.

@nl

P1476

Cost-effectiveness of latent t ...... nephrotic syndrome in children

@en

P2093

Benjamin L Laskin

http://www.w3.org/2001/XMLSchema#string

Daniel P Schauer

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Starke

http://www.w3.org/2001/XMLSchema#string

Jens Goebel

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study

Tuberculin skin test: estimation of positive and negative predictive values from routine data.

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis

Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa

Causes and costs of hospitalization of tuberculosis patients in the United States

Priorities for screening and treatment of latent tuberculosis infection in the United States

P304

22-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2012.06.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mark H Eckman

P577

2012-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22784996

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3827973

http://www.w3.org/2001/XMLSchema#string

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children

about

P2860

P2860

Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932